Ser Archer (Talk | contribs) |
Ser Archer (Talk | contribs) |
||
Line 94: | Line 94: | ||
<br> | <br> | ||
− | <h2> | + | <h2>Collaborate with <i>Tongji_China</i></h2> |
<h4><i>Tongji_China</i> has been working on an anti-cancer therapy based on neoantigen. We worked with them to build a statistical inference model which helped them to select their antigen for the therapy. We used Bayesian reverse probability to predict the genetic mutation site the patient may have based on the observed state of the patient, therefore, choosing a relative proper peptide for their treatment.</h4> | <h4><i>Tongji_China</i> has been working on an anti-cancer therapy based on neoantigen. We worked with them to build a statistical inference model which helped them to select their antigen for the therapy. We used Bayesian reverse probability to predict the genetic mutation site the patient may have based on the observed state of the patient, therefore, choosing a relative proper peptide for their treatment.</h4> | ||
<br> | <br> |
Revision as of 20:17, 16 October 2018